Embry Holdings Limited (HK:1388)
:1388
Want to see HK:1388 full AI Analyst Report?
1388 Stock Chart & Stats
HK$0.40
HK$0.02(4.35%)
At close: 4:00 PM EST
HK$0.40
HK$0.02(4.35%)
Day’s Range― - ―
52-Week RangeHK$0.28 - HK$0.60
Previous CloseN/A
Volume606.00K
Average Volume (3M)28.67K
Market Cap
HK$130.95M
Enterprise ValueHK$421.90M
Total Cash (Recent Filing)HK$189.79M
Total Debt (Recent Filing)HK$476.52M
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.60
Shares Outstanding422,416,630
10 Day Avg. Volume7,200
30 Day Avg. Volume28,666
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.10
Price to Sales (P/S)0.13
P/FCF Ratio-4.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsConsistently high gross margins (~70–75%) indicate robust unit economics and pricing power in core lingerie products. That durable margin cushion can absorb some SG&A pressure and supports potential operating-leverage gains if management reins in costs and restores profitability over months.
Manageable LeverageDebt-to-equity around 0.16–0.31 suggests the balance sheet is not heavily debt-financed, preserving capacity to access external funding or refinance. Lower leverage reduces near-term insolvency risk and gives flexibility to fund restructuring or working-capital needs during a multi-quarter recovery.
Vertically Integrated, Diversified ChannelsControl of design, manufacturing and sales plus multiple brands and mixed retail/wholesale distribution provides supply-chain control, quality oversight, and channel diversification. These structural capabilities support consistent product economics and lower dependence on external suppliers long-term.
Bears Say
Persistent UnprofitabilitySustained operating and net losses (net margin ~-22% in 2025) mean the business is not generating returns on capital. Continued unprofitability will deplete equity, limit reinvestment capacity, and likely require either material margin improvement or external funding to sustain operations over the medium term.
Weakening Cash GenerationOperating cash flow and free cash flow turned negative in 2024 and stayed negative into 2025, reducing liquidity and constraining working capital and reinvestment. Persistent negative cash generation elevates refinancing risk and limits the firm's ability to fund recovery without outside capital.
Balance-sheet Erosion & Negative ROEMaterial decline in equity and a negative ROE (~-16%) reflect capital erosion from sustained losses. A weaker equity base reduces the firm's shock absorbers, constrains strategic investment capacity and increases vulnerability to prolonged demand or cost shocks over the coming quarters.
Embry Holdings Limited News
1388 FAQ
What was Embry Holdings Limited’s price range in the past 12 months?
Embry Holdings Limited lowest stock price was HK$0.28 and its highest was HK$0.60 in the past 12 months.
What is Embry Holdings Limited’s market cap?
Embry Holdings Limited’s market cap is HK$130.95M.
When is Embry Holdings Limited’s upcoming earnings report date?
Embry Holdings Limited’s upcoming earnings report date is Aug 20, 2026 which is in 75 days.
How were Embry Holdings Limited’s earnings last quarter?
Embry Holdings Limited released its earnings results on Mar 27, 2026. The company reported -HK$0.462 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.462.
Is Embry Holdings Limited overvalued?
According to Wall Street analysts Embry Holdings Limited’s price is currently Overvalued.
Does Embry Holdings Limited pay dividends?
Embry Holdings Limited pays a Quarterly dividend of HK$0.02 which represents an annual dividend yield of N/A. See more information on Embry Holdings Limited dividends here
What is Embry Holdings Limited’s EPS estimate?
Embry Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Embry Holdings Limited have?
Embry Holdings Limited has 422,416,630 shares outstanding.
What happened to Embry Holdings Limited’s price movement after its last earnings report?
Embry Holdings Limited reported an EPS of -HK$0.462 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.389%.
Which hedge fund is a major shareholder of Embry Holdings Limited?
Currently, no hedge funds are holding shares in HK:1388
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Embry Holdings Limited
Embry Holdings Limited, an investment holding company, designs, researches, develops, manufactures, trades in, and sells ladies brassieres, panties, swimwear, and sleepwear. The company sells its lingerie products primarily under the EMBRY FORM, FANDECIE, COMFIT, E-BRA, IVU, IADORE, and LIZA CHENG brands. It also holds trademark and invests in properties. As of December 31, 2021, the company had 1,251 retail outlets comprising 1,049 concessionary counters and 202 retail stores in Mainland China, Hong Kong, and Macau. It also operates an online shop. The company was founded in 1975 and is headquartered in Kwai Chung, Hong Kong. Embry Holdings Limited is a subsidiary of Harmonious World Limited.
Technical Analysis
Justin Allen Holdings Limited
―
Bonny International Holding Ltd.
―
Regina Miracle International (Holdings) Limited
―
Cosmo Lady (China) Holdings Co. Ltd.
―
Eagle Nice (International) Holdings Ltd.
―